Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 3
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tramcoat 40 mg V/DCP/24/0013 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0013-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tramcoat 20 mg V/DCP/24/0012 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0012-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tramcoat 8 mg V/DCP/24/0011 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0011-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tralieve vet 20 mg V/DCP/18/0024 Dechra Regulatory B.V., Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0024-01 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-02 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-03 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-04 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-05 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-06 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-07 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-08 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-09 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-10 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-11 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-12 30 PVDH/PE/PVH/Al blisteris, 10 tablete -
Tralieve vet 80 mg V/DCP/18/0025 Dechra Regulatory B.V., Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0025-01 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-02 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-03 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-04 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-05 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-06 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-07 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-08 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-09 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-10 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-11 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-12 30 PVDH/PE/PVH/Al blisteris, 10 tablete -
Tralieve Vet 50 mg/ml V/DCP/19/0008 Le Vet Beheer B.V., Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tramadol hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0008-01 50 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/19/0008-02 50 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/19/0008-03 50 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/19/0008-04 50 mg/ml 6 Stikla flakons, 10 ml -
V/DCP/19/0008-05 50 mg/ml 6 Stikla flakons, 20 ml -
V/DCP/19/0008-06 50 mg/ml 6 Stikla flakons, 50 ml -
V/DCP/19/0008-07 50 mg/ml 10 Stikla flakons, 10 ml -
V/DCP/19/0008-08 50 mg/ml 10 Stikla flakons, 20 ml -
V/DCP/19/0008-09 50 mg/ml 10 Stikla flakons, 50 ml -
Topimec F - V/MRP/21/0072 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QP54AA51 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin, Clorsulon
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Limited, Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 29112021LI (29-Nov-2021)
Labelling text: [DOCX] 29112021M (29-Nov-2021)
Summary of product characteristics: [DOCX] 29112021ZA (29-Nov-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0072-01 1 ABPE pudele, 50 ml -
V/MRP/21/0072-02 1 ABPE pudele, 250 ml -
V/MRP/21/0072-03 1 ABPE pudele, 500 ml -
Eprizero 5 mg/ml V/DCP/13/0008 Norbrook Laboratories (Ireland) Limited, Īrija QP54AA04 cattle Vairāk

Medicinal product information

Pharmaceutical form: Pour-on solution
International name (active substance): Eprinomectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 10-May-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0008-01 5 mg/ml 1 ABPE konteiners (caurspīdīgs), 250 ml -
V/DCP/13/0008-02 5 mg/ml 1 ABPE konteiners (caurspīdīgs), 1000 ml -
V/DCP/13/0008-03 5 mg/ml 1 ABPE mugursomas tipa konteiners (balts), 1 l -
V/DCP/13/0008-04 5 mg/ml 1 ABPE mugursomas tipa konteiners (balts), 2,5 l -
V/DCP/13/0008-05 5 mg/ml 1 ABPE mugursomas tipa konteiners (balts), 5 l -
Antisedan Vet 5 mg/ml V/NRP/02/1452 Orion Corporation, Somija QV03AB90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Atipamezole hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Orion Corporation Orion Pharma, Somija
Date of authorisation/renewal: 06-Jun-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 27102022LI (16-Nov-2023)
Labelling text: [PDF] 171218M (16-Nov-2023)
Summary of product characteristics: [DOCX] 250320ZA (16-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1452-01 5 mg/ml 1 Stikla flakons, 10 ml [PDF] [JPG]
Parofor 140 mg/ml V/DCP/17/0035 Huvepharma NV, Beļģija QA07AA06 pigs; pre-ruminant cattle Vairāk

Medicinal product information

Pharmaceutical form: Solution for use in drinking water/milk
International name (active substance): Paromomycin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet Joint Stock Company., Bulgārija
Date of authorisation/renewal: 28-Jun-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0035-01 140 mg/ml 1 ABPE pudele, 125 ml -
V/DCP/17/0035-02 140 mg/ml 1 ABPE pudele, 250 ml -
V/DCP/17/0035-03 140 mg/ml 1 ABPE pudele, 500 ml -
V/DCP/17/0035-04 140 mg/ml 1 ABPE pudele, 1000 ml -
C-B-Gluconat 24% plus 6% - V/NRP/14/0004 Bela-pharm GmbH&Co.KG, Vācija QA12AX cattle; pigs; sheep; goats; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for infusion
International name (active substance): Boric Acid,Calcium gluconate,Magnesium chloride hexahydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 28-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/14/0004-01 1 Polipropilēna pudele, 500 ml [JPG] [JPG] [JPG] [PDF]
V/NRP/14/0004-02 6 Polipropilēna pudele, 500 ml -
V/NRP/14/0004-03 12 Polipropilēna pudele, 500 ml -
LV Calmasol-440 - V/NRP/19/0003 SIA "Vetmarket", Latvija QA12AX cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for infusion
International name (active substance): Calcium gluconate, Magnesium chloride hexahydrate, Boric Acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 020419_LI (04-Apr-2019)
Labelling text: [PDF] 020419_M (04-Apr-2019)
Summary of product characteristics: [PDF] 020419_ZA (04-Apr-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/19/0003-01 1 Plastmasas pudele, 500 ml -
LV Colisol Oral 2000000 IU/ml V/NRP/19/0024 SIA "Vetmarket", Latvija QA07AA10 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate for oral solution
International name (active substance): Colistin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 04062019_LI (04-Jun-2019)
Labelling text: [PDF] 04062019_M (04-Jun-2019)
Summary of product characteristics: [PDF] 04062019_ZA (04-Jun-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/19/0024-01 2000000 mg/ml 1 ABPE pudele, 1000 ml -
Dophasin 200000 IU/ml V/DCP/24/0032 Dopharma Research B.V., Nīderlande QJ01FA90 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tylosin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 30-Apr-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0032-01 1 Stikla flakons, 100 ml -
V/DCP/24/0032-02 1 Stikla flakons, 50 ml -
Milbemycin oxime / Praziquantel Alfamed 4 mg/10 mg - V/DCP/24/0059 Alfamed, Francija QP54AB51 cats; kittens Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0059-01 12 Blisteris, 2 tablete -
Milbemycin oxime / Praziquantel Alfamed 16 mg/40 mg - V/DCP/24/0060 Alfamed, Francija QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0060-01 24 Blisteris, 2 tablete -
Milbemycin oxime / Praziquantel Alfamed 12,5 mg/125 mg - V/DCP/24/0062 Alfamed, Francija QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0062-01 24 Blisteris, 2 tablete -
Milbemycin oxime / Praziquantel Alfamed 2,5 mg/25 mg - V/DCP/24/0061 Alfamed, Francija QP54AB51 dogs; puppies Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0061-01 12 Blisteris, 2 tablete -
Prazitel Plus XL - V/MRP/12/0061 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0061-01 1 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-02 1 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-03 1 PVH/PE/PHTFE/alumīnija blisteris, 5 tablete -
V/MRP/12/0061-04 1 PVH/PE/PHTFE/alumīnija blisteris, 6 tablete -
V/MRP/12/0061-05 1 PVH/PE/PHTFE/alumīnija blisteris, 8 tablete -
V/MRP/12/0061-06 1 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-07 1 PVH/PE/PHTFE/alumīnija blisteris, 12 tablete -
V/MRP/12/0061-08 1 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-09 1 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-10 1 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-11 1 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-12 2 PVH/PE/PHTFE/alumīnija blisteris, 12 tablete -
V/MRP/12/0061-13 2 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-14 3 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-15 2 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-16 2 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-17 2 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-18 21 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-19 11 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-20 3 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-21 5 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-22 13 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-23 4 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-24 3 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-25 4 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-26 17 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-27 5 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-28 4 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-29 19 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-30 4 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-31 6 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-32 11 PVH/PE/PHTFE/alumīnija blisteris, 8 tablete -
V/MRP/12/0061-33 23 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-34 6 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-35 7 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-36 5 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-37 13 PVH/PE/PHTFE/alumīnija blisteris, 8 tablete -
V/MRP/12/0061-38 53 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-39 6 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-40 7 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-41 29 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-42 6 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-43 7 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-44 15 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-45 9 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-46 10 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-47 17 PVH/PE/PHTFE/alumīnija blisteris, 12 tablete -
V/MRP/12/0061-48 103 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-49 13 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-50 25 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-51 14 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-52 15 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-53 25 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-54 50 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
Amcofen 2,5 mg/25 mg - V/MRP/19/0013 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small dogs; puppies weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 02-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 12012024LI (12-Jan-2024)
Labelling text: [PDF] 02052019M (02-May-2019)
Summary of product characteristics: [DOC] 120122024ZA (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0013-01 2,5/25 mg 2 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0013-02 2,5/25 mg 4 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0013-03 2,5/25 mg 48 Al/OPA/Al/PVH blisteris, 4 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy